USPTO serial 88311970
HCCBLOODTEST
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 11, 2020
- Examiner
- CORDOVA, RAUL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with HCCBLOODTEST?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $1,275
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rebeccah Gan
Rebeccah Gan Muncy, Geissler, Olds & Lowe, P.C.4000 Legato Road, Suite 310Fairfax, VA 22033UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry and science, namely, reagents used in science, namely, for forensic examinations and test kits used in science, in particular for verifying, diagnosing, monitoring and predicting the progress, treatment outcome and post treatment of illnesses, such as inflammatory, infectious, central nervous system, cardiovascular, neurological, endocrine, autoimmune and genetic diseases and cancer | ACTIVE | — |
| 005 | Pharmaceutical products, namely, reagents for medical use, namely, for verifying, diagnosing, monitoring and predicting the progress, treatment outcome and post-treatment of inflammatory, infectious, central nervous system, cardiovascular, neurological, endocrine, autoimmune and genetic diseases and cancer, in particular comprising of reagents, chemical preparations for the diagnosis of inflammatory, infectious, central nervous system, cardiovascular, neurological, endocrine, autoimmune and genetic diseases and cancer, assays, diagnostic test slides, and diagnostic test patches, sold as a unit | ACTIVE | — |
| 009 | Scientific instruments, namely, analyzers for biological substances and samples; laboratory apparatus, in particular apparatus for screening biological samples, for detecting the presence of substances in samples and for identifying sample types; all for research use or scientific use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 11, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Dec 23, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 23, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 23, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 23, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 23, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 16, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 16, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Dec 16, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 16, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 11, 2020 | R.SR | REGISTERED-SUPPLEMENTAL REGISTER | Your mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application. |
| Jul 7, 2020 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 1, 2020 | AAUA | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | — |
| Jun 30, 2020 | CNTA | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | — |
| Jun 30, 2020 | IUAA | USE AMENDMENT ACCEPTED | — |
| Jun 23, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 23, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 23, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 23, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 23, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 23, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 30, 2020 | AUPC | AMENDMENT TO USE PROCESSING COMPLETE | — |
| May 30, 2020 | IUAF | USE AMENDMENT FILED | — |
| May 29, 2020 | EAAU | TEAS AMENDMENT OF USE RECEIVED | — |
| May 8, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 8, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 7, 2020 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| May 5, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 5, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 5, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 14, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 14, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 9, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 27, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 27, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 27, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 2, 2020 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Feb 28, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 28, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 27, 2020 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Feb 27, 2020 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jan 3, 2020 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jan 3, 2020 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jan 3, 2020 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Dec 19, 2019 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Dec 13, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jul 5, 2019 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 6, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 6, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 6, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 15, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 15, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 14, 2019 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| May 10, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 10, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 10, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 3, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 14, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 2, 2019 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Feb 28, 2019 | ALIE | ASSIGNED TO LIE | — |
| Feb 26, 2019 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Feb 26, 2019 | NWAP | NEW APPLICATION ENTERED | — |